Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | BTX-6654 |
| Trade Name | |
| Synonyms | BTX6654|BTX 6654 |
| Drug Descriptions |
BTX-6654 is a bifunctional SOS1 degrader that potentially decreases downstream KRAS signaling and inhibits tumor growth (PMID: 38224565). |
| DrugClasses | SOS1 Inhibitor 17 |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Afatinib + BTX-6654 | Afatinib BTX-6654 | 0 | 0 |
| BTX-6654 | BTX-6654 | 1 | 0 |
| BTX-6654 + MRTX-1133 | BTX-6654 MRTX-1133 | 0 | 0 |
| BTX-6654 + Sotorasib | BTX-6654 Sotorasib | 0 | 0 |
| BTX-6654 + Trametinib | BTX-6654 Trametinib | 0 | 0 |